Immunotherapy of Spontaneously Arising Rat Mammary Tumours

Author(s):  
R. W. Baldwin ◽  
M. V. Pimm ◽  
N. Willmott
Keyword(s):  
BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sarah M. Bernhardt ◽  
Pallave Dasari ◽  
Danielle J. Glynn ◽  
Lucy Woolford ◽  
Lachlan M. Moldenhauer ◽  
...  

Abstract Background The Oncotype DX 21-gene Recurrence Score is predictive of adjuvant chemotherapy benefit for women with early-stage, estrogen receptor (ER)-positive, HER2-negative breast cancer. In premenopausal women, fluctuations in estrogen and progesterone during the menstrual cycle impact gene expression in hormone-responsive cancers. However, the extent to which menstrual cycling affects the Oncotype DX 21-gene signature remains unclear. Here, we investigate the impact of ovarian cycle stage on the 21-gene signature using a naturally cycling mouse model of breast cancer. Methods ER-positive mammary tumours were dissected from naturally cycling Mmtv-Pymt mice at either the estrus or diestrus phase of the ovarian cycle. The Oncotype DX 21-gene signature was assessed through quantitative real time-PCR, and a 21-gene experimental recurrence score analogous to the Oncotype DX Recurrence Score was calculated. Results Tumours collected at diestrus exhibited significant differences in expression of 6 Oncotype DX signature genes (Ki67, Ccnb1, Esr1, Erbb2, Grb7, Bag1; p ≤ 0.05) and a significant increase in 21-gene recurrence score (21.8 ± 2.4; mean ± SEM) compared to tumours dissected at estrus (15.5 ± 1.9; p = 0.03). Clustering analysis revealed a subgroup of tumours collected at diestrus characterised by increased expression of proliferation- (p < 0.001) and invasion-group (p = 0.01) genes, and increased 21-gene recurrence score (p = 0.01). No correlation between ER, PR, HER2, and KI67 protein abundance measured by Western blot and abundance of mRNA for the corresponding gene was observed, suggesting that gene expression is more susceptible to hormone-induced fluctuation compared to protein expression. Conclusions Ovarian cycle stage at the time of tissue collection critically affects the 21-gene signature in Mmtv-Pymt murine mammary tumours. Further studies are required to determine whether Oncotype DX Recurrence Scores in women are similarly affected by menstrual cycle stage.


1984 ◽  
Vol 25 (2) ◽  
pp. 187-194 ◽  
Author(s):  
B. Arun ◽  
M. Udayachander ◽  
A. Meenakshi

2012 ◽  
Vol 193 (1) ◽  
pp. 24-31 ◽  
Author(s):  
A.J.F. Matos ◽  
C.S. Baptista ◽  
M.F. Gärtner ◽  
G.R. Rutteman
Keyword(s):  

1995 ◽  
Vol 47 (5) ◽  
pp. 382-387 ◽  
Author(s):  
ERIC ALLEMANN ◽  
NICOLE BRASSEUR ◽  
OUHIDA BENREZZAK ◽  
JACQUES ROUSSEAU ◽  
SVETLANA V. KUDREVICH ◽  
...  

1966 ◽  
Vol 36 (4) ◽  
pp. 409-414 ◽  
Author(s):  
B. G. MOBBS

SUMMARY The uptake of injected [6,7-3H]oestradiol by 9,10-dimethyl-1,2-benzanthracene-induced mammary tumours of the rat was investigated. Hormone-responsive adenomata differed from unresponsive adenomata in their ability to concentrate the hormone. The concentration of tritiated oestrogen present as free steroid in adenomata which failed to regress after ovariectomy was twice that found in muscle 20 min. after injection, and this ratio did not change significantly for 2 hr. after injection. Hormone-responsive adenomata concentrated the hormone to a much greater extent: the amount of tritiated oestrogen/mg. wet weight continued to rise for 100 min. after injection, when the concentration of radioactive steroid present in the tumours was 8–20 times that present in muscle. In this respect, the hormone-responsive tumours behaved in a similar way to the uterus and other target organs for oestrogen which have been investigated by other authors. Mixed adenomata, that is, those which contained both hormone-responsive and -unresponsive tissue, and fibroadenomata concentrated the injected oestradiol to an extent intermediate between the wholly responsive and wholly unresponsive adenomata.


Sign in / Sign up

Export Citation Format

Share Document